Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT06669533

Use Misoprostol to Optimize Prevention of Cervical Cancer

Conditions: Cervical Cancers

Sex: Female

Ages: 25 Years – N/A

Healthy volunteers: Yes

Phase: NA

Enrollment: 840

Sponsor: University of Alabama at Birmingham

Location: Cameroon Baptist Convention Health Core, EtougEbe Baptist Hospital Yaoundé Yaoundé Center Region

Summary

This is a double-blind randomized controlled trial of 420 non-pregnant women undergoing cancer screening by visual inspection with acetic acid (VIA) who have Type 3 transformation zone (TZ) and randomized to receive either Misoprostol or placebo.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of Type 3 TZ confirmed on exam prior to randomization * Age 25 years or older Exclusion Criteria: * With Type 1 or 2 TZ prior to randomization * Currently pregnant * History of hysterectomy * Any cancerous lesions * Active cervicitis

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06669533). StuddyBuddy aggregates publicly available trial information.